Abbonarsi

Asthma and COPD versus phenotypic traits: Toward precision medicine in chronic airway disease - 21/09/21

Doi : 10.1016/j.rmed.2021.106529 
Signe Vedel-Krogh a, b, c, Sune Fallgaard Nielsen a, b, c, Børge Grønne Nordestgaard a, b, c, Peter Lange b, c, d, e, Jørgen Vestbo f, g, ⁎
a Department of Clinical Biochemistry, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark 
b The Copenhagen General Population Study, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark 
c Faculty of Health and Medical Sciences, University of Copenhagen, Denmark 
d Department of Public Health, Section of Epidemiology, University of Copenhagen, Denmark 
e Medical Department, Respiratory Section, Copenhagen University Hospital – Herlev and Gentofte, Copenhagen, Denmark 
f Division of Infection, Immunity and Respiratory Medicine, School of Biological Sciences, The University of Manchester, Manchester, United Kingdom 
g Manchester University NHS Foundation Trust, Manchester Academic Health Science Centre, Southmoor Road, Manchester, M23 9LT, United Kingdom 

∗Corresponding author. Wythenshawe Hospital, Southmoor Road, Manchester, M23 9LT, United Kingdom.Wythenshawe HospitalSouthmoor RoadManchesterM23 9LTUnited Kingdom

Abstract

Background

Asthma and COPD diagnoses are used to classify chronic airway diseases; however, both diseases are related to phenotypic traits like allergy, obesity, cough, sputum production, low-grade inflammation, smoking, elevated blood eosinophil count, comorbidities, and occupational exposures. Whether such traits can replace asthma and COPD diagnoses when assessing risk of exacerbation is unclear. We tested the hypothesis that individuals with either asthma or COPD diagnoses have similar risk of moderate and severe exacerbations when adjusted for differences in phenotypic traits.

Methods

From the Copenhagen General Population Study, a cohort study of the general population, we included 7190 individuals with chronic airway disease. Phenotypic traits were recorded at baseline and risk of exacerbations was assessed during follow-up from 2003 to 2013.

Results

The incidence rate ratio (IRR) of moderate exacerbations in individuals with clinical COPD was 1.61 (95% Confidence Interval, 1.27–2.02) compared to individuals with asthma in a model only adjusted for age, sex, and education, but after the inclusion of phenotypic traits IRR was 1.05 (0.82–1.35). Corresponding IRRs of severe exacerbations in individuals with clinical COPD versus asthma were 3.82 (2.73–5.35) and 2.28 (1.63–3.20), respectively.

Conclusions

When taking phenotypic traits into account, individuals with asthma and COPD had comparable risk of moderate exacerbations; however, corresponding risk of severe exacerbations was higher in individuals with COPD than in those with asthma.

Il testo completo di questo articolo è disponibile in PDF.

Highlights

•
Should prognostic traits be preferred over diagnostic labelling in asthma and COPD?
•
Prognostic traits are sufficient for risk prediction of moderate exacerbations.
•
Diagnostic labels offer an advantage for risk prediction of severe exacerbations.
•
When assessing prognosis of chronic airway disease, diagnostic labels cannot fully be discarded.

Il testo completo di questo articolo è disponibile in PDF.

Keywords : Airway obstruction, Prognosis, Exacerbations, Lung disease


Mappa


© 2021  Elsevier Ltd. Tutti i diritti riservati.
Aggiungere alla mia biblioteca Togliere dalla mia biblioteca Stampare
Esportazione

    Citazioni Export

  • File

  • Contenuto

Vol 186

Articolo 106529- settembre 2021 Ritorno al numero
Articolo precedente Articolo precedente
  • Impact of COPD exacerbations leading to hospitalization on general and disease-specific quality of life
  • Erin R. Camac, Helen Voelker, Gerard J. Criner, for the COPD Clinical Research Network and the Canadian Institutes of Health Research
| Articolo seguente Articolo seguente
  • The cardiovascular phenotype of Chronic Obstructive Pulmonary Disease (COPD): Applying machine learning to the prediction of cardiovascular comorbidities
  • Vasilis Nikolaou, Sebastiano Massaro, Wolfgang Garn, Masoud Fakhimi, Lampros Stergioulas, David Price

Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.

Già abbonato a @@106933@@ rivista ?

@@150455@@ Voir plus

Il mio account


Dichiarazione CNIL

EM-CONSULTE.COM è registrato presso la CNIL, dichiarazione n. 1286925.

Ai sensi della legge n. 78-17 del 6 gennaio 1978 sull'informatica, sui file e sulle libertà, Lei puo' esercitare i diritti di opposizione (art.26 della legge), di accesso (art.34 a 38 Legge), e di rettifica (art.36 della legge) per i dati che La riguardano. Lei puo' cosi chiedere che siano rettificati, compeltati, chiariti, aggiornati o cancellati i suoi dati personali inesati, incompleti, equivoci, obsoleti o la cui raccolta o di uso o di conservazione sono vietati.
Le informazioni relative ai visitatori del nostro sito, compresa la loro identità, sono confidenziali.
Il responsabile del sito si impegna sull'onore a rispettare le condizioni legali di confidenzialità applicabili in Francia e a non divulgare tali informazioni a terzi.


Tutto il contenuto di questo sito: Copyright © 2026 Elsevier, i suoi licenziatari e contributori. Tutti i diritti sono riservati. Inclusi diritti per estrazione di testo e di dati, addestramento dell’intelligenza artificiale, e tecnologie simili. Per tutto il contenuto ‘open access’ sono applicati i termini della licenza Creative Commons.